New Delhi, A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue, according to the US Food and Drug ...
Drug maker Cipla on Friday said it has launched an integrated lung diagnostics and wellness centre in the national capital. Located in Lajpat Nagar, it will be India's first-of-its-kind ...
Cipla Ltd, one of India’s leading pharmaceutical companies, reported a stronger-than-expected second-quarter performance on Thursday, driven by sustained demand for its respiratory drugs and expanding chronic portfolio.Record Quarter for ...
Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the fourth quarter ended March 31, 2025. Photograph: Danish Siddiqui/Reuters ...
The US government's order to pharma firms to lower the cost of prescription medicines within 30 days will not impact Indian generic drugmakers, Cipla MD and Global CEO Umang ...
MUMBAI: Cipla on Wednesday said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza - inhalation human insulin ...
Drug major Cipla expects to commence supplies to the US market from its China facility in the second half of the current fiscal after getting approval from the American ...
Mumbai: Some members of the Hamied family that founded Cipla are set to offload shares via block deals, said people aware of the matter, eight months after promoter-stake-sale talks ...
Shivali Rajput, 43, excels in her job, earns well and overshoots her career targets year after year. But when it comes to managing her weight, Rajput’s efforts have come ...
Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments in the domestic market. The Mumbai-based company is also looking ...